Some researchers seek to establish a single abnormal result on a set of biomarker-based tests as sufficient to diagnose the ...

Nearly 7 million Americans have Alzheimer's disease, and this number is predicted to double by 2060. While aging and genetic predisposition are the most important risk factors for Alzheimer's, ...

By examining RNA in hundreds of thousands of individual brain cells, scientists further support that alcohol use disorder could accelerate Alzheimer's disease progression, paving the way for future ...

Socioeconomic factors such as education, occupation, and wealth influence the likelihood of developing cognitive impairment or dementia in later life and whether a person is likely to recover ...

Nov. 6, 2024 — Older people who are sleepy during the day or lack enthusiasm for activities due to sleep issues may be more likely to develop a syndrome that can lead to dementia, according to a ...

Neurologist Dona Murphey, the founder of website PrognosUs, hopes her platform can give caregivers a place to find support in ...

An analysis of brains at various stages of Alzheimer's found that neurons called inhibitory neurons are the first to be affected by the disease.

There is an increasing amount of research into the link between certain infections and dementia, including herpes, pneumonia, syphilis, Lyme disease and gum disease. Research shows that dementia is ...

SAVANNAH, Ga. (WSAV) – The Walk to End Alzheimer’s is the world’s largest event to fight Alzheimer’s, and Coastal Georgia ...

DiADeM is a tool to support GPs in diagnosing dementia for people living with advanced dementia in a care home setting. It has been developed by the Yorkshire and Humber Dementia Strategic Clinical ...

During National Family Caregivers and National Alzheimer’s Disease Awareness Month in November, and all year round, the Alzheimer’s Association offers free resources to families caring for a loved one ...

Positive results of a phase 2 study support the potential to repurpose intranasal insulin and the SGLT2 inhibitor empagliflozin for Alzheimer’s disease.